'Baboon syndrome' following oral roxithromycin [1]

Clinical and Experimental Dermatology

Volumn 27, Issue 6, 2002, Pages 523-

  Amichai, B ^a   Grunwald, M H ^a  

^a Huzot Ashkelon Out Patient Clinic   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; ROXITHROMYCIN;

ADULT; ANTIBIOTIC THERAPY; BABOON SYNDROME; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; LETTER; MALE; METABOLIC DISORDER; NEUROLOGIC DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; RASH; SKIN ALLERGY; STEROID THERAPY; SYSTEMIC DISEASE; UPPER RESPIRATORY TRACT INFECTION;

EID: 0036408887     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.10821.x     Document Type: Letter

References (3)

1. Product Information: Roxithromycin (Rulid®) Roussel Uclar, 1996.
2. Dawn G, Kanwar AJ, Dhar S. Nail pigmentation due to roxithromycin. Dermatology 1995; 191: 342-3.
3. Kohler LD, Schonlein K, Kautzky F, Vogt HJ. Diagnosis at first glance: the baboon syndrome. Int J Dermatol 1996; 35: 502-3.